相关实验视频
Updated: May 20, 2025
08:09
Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
11.3K
血管合作:在口腔状细胞癌中是一个有前途的治疗策略
1Pathology, Institute of Post Graduate Medical Education and Research (IPGMER) and Seth Sukhlal Karnani Memorial (SSKM) Hospital, Kolkata, IND.
Cureus
|March 27, 2025
概括
血管合作,癌细胞劫持血管,在口腔状细胞癌 (OSCC) 中很常见. 高基67标签指数 (LI) 与船只选择相关,这表明它表明具有侵略性的OSCC并有助于预后.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 血管合作是一种癌细胞利用现有的血管的机制,与各种癌症的不良结果有关.
- 它在口腔状细胞癌 (OSCC) 中的作用尚未得到研究.
- 这项研究调查了OSCC中的船只选择及其预后意义.
研究的目的:
- 确定血管选择与口腔状细胞癌 (OSCC) 的Ki67标记指数 (LI) 之间的关联.
- 评估船只选择在OSCC中的预后作用.
主要方法:
- 对39个OSCC活检标本的回顾性分析.
- 对于CD34,p40和Ki67.6的免疫组织化学
- 血管选择和Ki67 LI. 的组织病理学评估.
主要成果:
- 在71.79%的OSCC案例中观察到船只选择.
- 在船只选择和Ki67 LI>10%之间发现了显著的关联 (p = 0.0013).
- 大多数患者是男性 (3:1比),年龄在31-50岁之间,舌头癌最常见.
结论:
- 血管选择是OSCC中普遍存在的特征,表明具有侵略性瘤潜力.
- 对血管选择和Ki67 LI的组合本病理学评估可以帮助预测OSCC的预后.
相关概念视频
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K